Neuroprotective Effects of the Cultivated Chondrus crispus in a C. elegans Model of Parkinson’s Disease

By Liu Jinghua   Banskota Arjun H.   Critchley Alan T.   Hafting Jeff   Prithiviraj Balakrishnan  

Marine Drugs, Vol. 13, Iss. 4, 2015-04 ,pp. : 2250-2266

MDPI

Access to resources Recommend Favorite

Tyrosinase-Expressing Neuronal Cell Line as in Vitro Model of Parkinson’s Disease

By Hasegawa Takafumi  

International Journal of Molecular Sciences, Vol. 11, Iss. 3, 2010-03 ,pp. : 1082-1089

MDPI

Access to resources Recommend Favorite

Oxidative Stress Mechanisms Underlying Parkinson’s Disease-Associated Neurodegeneration in C. elegans

By Chakraborty Sudipta   Bornhorst Julia   Nguyen Thuy T.   Aschner Michael  

International Journal of Molecular Sciences, Vol. 14, Iss. 11, 2013-11 ,pp. : 23103-23128

MDPI

Access to resources Recommend Favorite

Auraptene and Other Prenyloxyphenylpropanoids Suppress Microglial Activation and Dopaminergic Neuronal Cell Death in a Lipopolysaccharide-Induced Model of Parkinson’s Disease

By Okuyama Satoshi   Semba Tomoki   Toyoda Nobuki   Epifano Francesco   Genovese Salvatore   Fiorito Serena   Taddeo Vito Alessandro   Sawamoto Atsushi   Nakajima Mitsunari   Furukawa Yoshiko  

International Journal of Molecular Sciences, Vol. 17, Iss. 10, 2016-10 ,pp. : 1716-1716

MDPI

Access to resources Recommend Favorite

Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson’s Disease in Rats

By Chen Guangxin   Liu Juxiong   Jiang Liqiang   Ran Xin   He Dewei   Li Yuhang   Huang Bingxu   Wang Wei   Fu Shoupeng  

International Journal of Molecular Sciences, Vol. 19, Iss. 1, 2017-12 ,pp. : 12-12

MDPI

Access to resources Recommend Favorite